CAS 2945220-41-5
:Osimertinib Impurity 15
Description:
Osimertinib Impurity 15, with the CAS number 2945220-41-5, is a chemical compound associated with the pharmaceutical development of osimertinib, an epidermal growth factor receptor (EGFR) inhibitor used in cancer therapy, particularly for non-small cell lung cancer. While specific characteristics of Osimertinib Impurity 15 may not be widely documented, impurities in pharmaceutical compounds typically exhibit structural similarities to the parent compound, potentially affecting its efficacy and safety profile. Such impurities can arise during the synthesis or storage of the drug and may influence pharmacokinetics, stability, and overall therapeutic outcomes. The characterization of impurities often involves techniques such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) spectroscopy to determine their chemical structure, purity, and concentration. Understanding these characteristics is crucial for regulatory compliance and ensuring the safety and effectiveness of the final pharmaceutical product.
- N1,N5-bis(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-2-methylenepentanediamide
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
